Skip to main content
Caplight Logo









Neurent Medical

Neurent Medical

Private
IrelandHealthcare & Life Scienceshttps://neuromark.com/

Last Round

Series C

Feb 11, 2026

Total Funding Raised

$129.47M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Neurent Medical is a medical device company that develops minimally invasive, non-surgical treatments for chronic inflammatory sinonasal diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

chronic rhinitis treatmentradiofrequency ablationRF ablationENTotolaryngologyminimally invasive procedurein-office procedurenerve ablationimpedance-controlled RFmedical devicerhinologyrunny nose treatmentposterior nasal nervesPNNsingle-use deviceCPT code

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurent Medical Comparables

Compare Neurent Medical with similar companies based on industry and business-model similarity.

Neurent Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aerin Medical
93%
Stryker Corporation
74%
Medtronic
69%

Neurent Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CFeb 11, 2026
DebtDec 18, 2024
Series BJan 20, 2021
GrantJul 9, 2020
Series AMay 28, 2018

Key People

Founding team and executive leadership

David Townley

Co-Founder Chief Technology Officer

Founding Team

Declan Daly

Chief Financial Officer

Executive Team

Neurent Medical Investors

Notable investors and investment history

Neurent Medical investors
InvestorRounds
Atlantic Bridge CapitalSeries C, Series B, Series A
EQT Life SciencesSeries C, Series B
Claret Capital PartnersDebt
Western Development CommissionSeries A
Fountain Healthcare PartnersSeries C, Series B, Series A
EIT HealthGrant
Sofinnova PartnersSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 17, 3x the trailing average.

  • Feb 11, 2026

    $74M round led by MVM Life Science Partners.

Neurent Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neurent Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neurent Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersIreland
Employee Range85
Year Founded2015
Last FundingFeb 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?